Ignite Creation Date:
2025-12-25 @ 5:10 AM
Ignite Modification Date:
2026-02-25 @ 5:39 PM
Study NCT ID:
NCT06697327
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-05-14
First Post:
2024-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Sponsor:
Anhui Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-12
First Submit QC Date:
None
Study First Post Date:
2024-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-10
Last Update Post Date:
2025-05-14
Last Update Post Date Type:
ACTUAL